Evidence map›Paper›PMID 39332406›Full record

ArticleStem cell reports2024

Abnormal synaptic architecture in iPSC-derived neurons from a multi-generational family with genetic Creutzfeldt-Jakob disease.

Aldana D Gojanovich, Nhat T T Le, Robert C C Mercer, Seonmi Park, Bei Wu, Alice Anane, Janelle S Vultaggio, Gustavo Mostoslavsky, David A Harris

Abstract read
In one paragraph

Article in Stem cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. PrPStem cell reports · 2026
    Article
  3. Article
  4. Enhanced lysosomal activity prevents infection with PrPThe Journal of biological chemistry · 2026
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aldana D GojanovichCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
Nhat T T LeDepartment of Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Robert C C MercerDepartment of Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Seonmi ParkCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
Bei WuDepartment of Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Alice AnaneCreutzfeldt-Jakob Disease Foundation, Pardes Hanna-Karkur, Israel.
Janelle S VultaggioDepartment of Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Gustavo MostoslavskyCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA; Department of Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA; Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: gmostosl@bu.edu.
David A HarrisDepartment of Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: daharris@bu.edu.

Funding

Zoonotic potential of CWD and influence of environmental contamination on prion propagationP01AI077774 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CLAUDIO SOTO · 2008 to 2026
$36.1M
Mechanisms of Prion Protein ToxicityR01NS065244 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARRIS, DAVID A · 2010 to 2025
$8.9M
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV InfectionR01DA051889 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, CHRISTINE, GUMMULURU, SURYARAM · 2020 to 2024
$3.5M
Modeling prion diseases using human iPSC-derived neuronsR21NS111499 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARRIS, DAVID A, MOSTOSLAVSKY, GUSTAVO · 2019 to 2019
$488k
Genomic and Proteomic Analysis of Prion SynaptotoxicityR21NS107755 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARRIS, DAVID A · 2018 to 2019
$454k
NIAID NIH HHS P01 AI077774NIDA NIH HHS R01 DA051889NINDS NIH HHS R01 NS065244NINDS NIH HHS R21 NS107755NINDS NIH HHS R21 NS111499
6 · The paper itself

Abstract

Genetic prion diseases are caused by mutations in PRNP, which encodes the prion protein (PrP

Indexed as

Creutzfeldt-Jakob SyndromeInduced Pluripotent Stem CellsNeuronsSynapsesAdultCell DifferentiationFemaleHumansMaleMiddle AgedMutationPedigreePrion ProteinsPrPSc ProteinsReceptors, N-Methyl-D-AspartatePrion ProteinsPRNP protein, humanPrPSc ProteinsReceptors, N-Methyl-D-AspartateE200Kgenetic prion diseaseiPSCneurodegenerationprionprion diseasePrPPrPScsynapse

Identifiers

PMID39332406
PMCPMC11561462

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.